Abstract
Homoharringtonine, an alkaloid indigenous to China, was studied for its effect on fibroblast growth in cell culture and on intraocular proliferation produced in rabbits by injecting homologous fibroblasts into the vitreous. The results demonstrate that homoharringtonine reduced the cell growth by 50% at a concentration of 0.005 mg/l in vitro, significantly inhibited vitreous proliferation, and prevented the occurrence of retinal detachment in vivo. Light and electron microscopy revealed no ocular toxicity in drug-treated eyes. Homoharringtonine may be of considerable value in the prevention and treatment of intraocular proliferation in patients.
Similar content being viewed by others
References
Avni I, Belkin M, Hereberg A, Blumenthal M (1984) Intravitreal 5-fluorouracil in the prevention of post-traumatic vitreous proliferation. Ophthalmologica 188:5–8
Binder S, Riss B, Skorpik C, Kulnig W (1983) Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil. Graefe's Arch Clin Exp Ophthalmol 221: 126–129
Blumenkranz MS, Claflin A, Hajek AS (1984) Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol 102:598–607
Bockxmeer FM van, Martin CE, Constable IJ (1985) Models for assessing scar tissue inhibitors. Retina 5:47–60
Bockxmeer FM van, Martin CE, Thompson DE, Constable IJ (1985) Taxol for the treatment of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:1140–1147
Faulborn J, Topping TM (1978) proliferations in the vitreous cavity after perforating injuries. A histopathological study. Graefe's Arch Clin Exp Ophthalmol 205:157–166
Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing (1979) Chemical, pharmacological and clinical studies on the antitumor active principle ofCephalotaxus hainanensis Li. Chin J Oncol 1: 176–181 (in Chinese)
Tano Y, Chandler D, Machemer R (1980) Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 90:810–816
Wiedemann P, Kirmani M, Sorgente N, Ryan SJ (1983) Control of experimental massive periretinal proliferation by daunomycin: dose-response relation. Graefe's Arch Clin Exp Ophthalmol 220:233–235
Wiedemann P, Sorgente N, Bekhor C, Patterson R, Tran T, Ryan SJ (1985) Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:719–725
Author information
Authors and Affiliations
Additional information
This study was supported by The National Science Fund
Rights and permissions
About this article
Cite this article
Junping, L., Chunzhi, H., Shuiqing, Z. et al. Inhibition of intraocular proliferation by homoharringtonine. Graefe's Arch Clin Exp Ophthalmol 226, 367–370 (1988). https://doi.org/10.1007/BF02172969
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02172969